Completed NCT00107731
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Birmingham Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug i A study involving a medication or substance. Over 18 Years
Countries United States, Australia, France, ...
Sponsor AstraZeneca
Condition Bipolarity Completed NCT01244815
This study is completed. It is testing asenapine Treatment for Bipolarity.
Location not clearly listed Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 10 Years to 17 Years
Countries
Sponsor Organon and Co
Condition Bipolarity Completed NCT00741598
This study is completed in the United States. It is testing galantamine for Bipolarity.
Multiple locations, including Boston Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries United States
Sponsor Icahn School of Medicine at Mount Sinai
Condition Bipolarity Completed NCT00266630
This study is completed in Japan. It is testing olanzapine for Bipolarity.
Multiple locations, including Akita Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 20 Years to 65 Years
Countries Japan
Sponsor Eli Lilly and Company
Condition Bipolarity Completed NCT00254774
This study is completed in Germany. It is testing quetiapine Compared With Valproate for Bipolarity.
Multiple locations, including Berlin Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries Germany
Sponsor AstraZeneca
Condition Bipolarity Completed NCT00114686
This study is completed in the United States. It is testing Quetiapine Fumarate (SEROQUEL®) for Bipolarity.
Multiple locations, including Cerritos Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 21 Years to 60 Years
Countries United States
Sponsor AstraZeneca
Condition Bipolarity Completed NCT00081380
This study is completed in the United States and in Canada. It is testing seroquel Plus Mood Stabilizer for Bipolarity.
Multiple locations, including Birmingham Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug Over 18 Years
Countries United States, Canada
Sponsor AstraZeneca
Condition Bipolarity Completed NCT00150553
This study is completed. It is testing SPD417 for Bipolarity.
Location not clearly listed Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug Over 18 Years
Countries
Sponsor Validus Pharmaceuticals
Condition Bipolarity Completed NCT00550394
This summary needs review. Please check the official study record and contact the research team for details.
In Cincinnati Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 12 Years to 25 Years
Countries United States
Sponsor University of Cincinnati
Condition Bipolarity Completed NCT02481895
This summary needs review. Please check the official study record and contact the research team for details.
In Barcelona Why is this study shown? This study is directly about Bipolarity.
Bipolarity Behavioral From 18 Years to 60 Years
Countries Spain
Sponsor Consorcio Centro de Investigación Biomédica en Red (CIBER)
Condition Bipolarity Completed NCT01197846
This study is completed in Spain. It focuses on Bipolarity.
Multiple locations, including Barcelona Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries Spain
Sponsor Centro de Investigación Biomédica en Red de Salud Mental
Condition Bipolarity Completed NCT01567527
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Birmingham Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries United States, Canada, Japan, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Bipolarity